Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases.
Journal of medicinal chemistry • Vol. 61, Issue 16 • 2018
Targeting the hypoxia-sensing pathway in clinical hematology.
Stem cells translational medicine • Vol. 3, Issue 2 • 2014
First-in-class anemia drug takes aim at Amgen's dominion.
Nature biotechnology • Vol. 31, Issue 11 • 2013
A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity.
Analytical biochemistry • Vol. 330, Issue 1 • 2004